Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. is a biopharmaceutical company focused on developing lipid-based therapies for underserved medical needs, particularly in infectious diseases, cardiovascular, and neurological disorders. The company utilizes its proprietary lipid nanotechnology platform to develop novel oral drug delivery systems aimed at improving the safety and efficacy of existing medications.
Company News
BEDMINSTER, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (LNC) platform delivery technology, announces the recent successful treatment of a 22-year-old male with polymicrobial n...
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers F...
Biotech penny stocks to watch this week. The post Penny Stocks To Buy Now? 3 to Watch With Big News appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Matinas Biopharma Holdings, Inc. (MTNB) delivered earnings and revenue surprises of 0% and 265.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
There's trouble ahead, but a few new solutions are on the way too.